Skip to main content
. 2014 Jun;58(6):3306–3311. doi: 10.1128/AAC.01920-13

FIG 3.

FIG 3

Predicted individual concentration-activity relationships for sutezolid (U-480) and its main metabolite (U-603) against intracellular M. tuberculosis on the basis of the fixed-effect estimates of Table 1. The vertical axis indicates the change in mycobacterial viability per day of whole-blood culture, with negative values indicating killing. Dotted lines indicate the concentrations required for intracellular bacteriostasis.